Market Overview:
The global intrauterine devices market size reached US$ 4.15 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2027, exhibiting at a CAGR of 4.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
An intrauterine device (IUD) is a T-shaped plastic or copper birth control medical device inserted into the uterus to prevent pregnancy. It releases copper into the womb, which alters the cervical mucus and makes it difficult for the sperm to reach an egg and survive. It can also stop a fertilized egg from being able to implant itself. As it is compact, safe and cost-effective and has no hormonal side effects, such as acne, headaches, or breast tenderness, IUD is widely preferred over other methods of contraception. At present, it is available in different types that can last for an extended period of 5 to 10 years.
Intrauterine Devices Market Trends:
Increasing cases of unplanned and unwanted pregnancies represent one of the key factors positively influencing the demand for IUDs across the globe. In addition, hormonal IUDs can be used to treat people suffering from severe cramps, heavy periods, and anemia. Apart from this, initiatives undertaken by health agencies of numerous countries, along with non-profit organizations (NPOs), to generate awareness about family planning; the advantages of birth control measures; and health-related issues caused by unplanned pregnancies are promoting the market growth. In addition, as IUDs have an extremely low risk of ectopic pregnancy, they are gaining immense traction among nulliparous women and adolescents who have never given birth and are at higher risk for adverse birth outcomes like breast and reproductive cancers. Besides this, the development of advanced product variants, such as postpartum, slimmer and reusable IUDs, with fewer side effects is anticipated to offer lucrative growth opportunities to industry investors in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intrauterine devices market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on product and end-use.
Breakup by Product
- Hormonal Intrauterine Device
- Copper Intrauterine Device
Hormonal intrauterine devices hold the majority of the global intrauterine devices market share as they are cost-effective and long-lasting and can be used to treat people suffering from severe cramps, heavy periods, and anemia.
Breakup by End-Use
- Hospitals
- Gynaecology Clinics
- Community Healthcare
- Others
On the basis of end-use segment, the report has segregated the market into hospitals, gynaecology clinics, community healthcare and others.
Breakup by Region
- Europe
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
North America enjoys the leading position in the market share due to the increasing number of mistimed and unplanned pregnancy cases in the region.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being Actavis, Bayer, Teva Pharmaceuticals, Allergan, Eurogine, OCON Medical, Pregna, HLL Lifecare, HRA Pharma, ANI Pharmaceuticals, Besins HealthCare, SMB, etc
This report provides a deep insight into the global intrauterine devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the intrauterine devices industry in any manner.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product, End-Use, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Companies Covered |
Actavis, Bayer, Teva Pharmaceuticals, Allergan, Eurogine, OCON Medical, Pregna, HLL Lifecare, HRA Pharma, ANI Pharmaceuticals, Besins HealthCare, SMB |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special reque |
Key Questions Answered in This Report:
- How has the global intrauterine devices market performed so far and how will it perform in the coming years?
- What are the key regions in the global intrauterine devices market?
- What has been the impact of COVID-19 on the global intrauterine devices market?
- Which are the popular products in the global intrauterine devices market?
- What are the key end-use segments in the global intrauterine devices market?
- What are the various stages in the value chain of the global intrauterine devices market?
- What are the key driving factors and challenges in the global intrauterine devices market?
- What is the structure of the global intrauterine devices market and who are the key players?
- What is the degree of competition in the global intrauterine devices market?
- How are intrauterine devices manufactured?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Intrauterine Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product
5.5 Market Breakup by End-Use
5.6 Market Breakup by Region
5.7 Market Forecast
5.8 SWOT Analysis
5.8.1 Overview
5.8.2 Strengths
5.8.3 Weaknesses
5.8.4 Opportunities
5.8.5 Threats
5.9 Value Chain Analysis
5.9.1 Overview
5.9.2 Research and Development
5.9.3 Raw Material Procurement
5.9.4 Manufacturing
5.9.5 Marketing
5.9.6 Distribution
5.9.7 End-Use
5.10 Porters Five Forces Analysis
5.10.1 Overview
5.10.2 Bargaining Power of Buyers
5.10.3 Bargaining Power of Suppliers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes
6 Market Breakup by Product
6.1 Hormonal Intrauterine Device
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Copper Intrauterine Device
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by End-Use
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Gynaecology Clinics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Community Healthcare
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 Europe
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 North America
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 Intrauterine Devices Manufacturing Process
9.1 Product Overview
9.2 Raw Material Requirements
9.3 Manufacturing Process
9.4 Key Success and Risk Factors
10 Competitive Landscape
10.1 Market Structure
10.2 Key Players
10.3 Profiles of Key Players
10.3.1 Actavis
10.3.2 Bayer
10.3.3 Teva Pharmaceutical
10.3.4 Allergen
10.3.5 ANI Pharmaceuticals
10.3.6 Eurogine
10.3.7 OCON Medical
10.3.8 Pregna
10.3.9 SMB Corporation
10.3.10 HLL Lifecare
10.3.11 HRA Pharma
10.3.12 Besins HealthCare
List of Figures
Figure 1: Global: Intrauterine Devices Market: Major Drivers and Challenges
Figure 2: Global: Intrauterine Devices Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Intrauterine Devices Market: Breakup by Product (in %), 2021
Figure 4: Global: Intrauterine Devices Market: Breakup by End-Use (in %), 2021
Figure 5: Global: Intrauterine Devices Market: Breakup by Region (in %), 2021
Figure 6: Global: Intrauterine Devices Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 7: Global: Intrauterine Devices Industry: SWOT Analysis
Figure 8: Global: Intrauterine Devices Industry: Value Chain Analysis
Figure 9: Global: Intrauterine Devices Industry: Porter’s Five Forces Analysis
Figure 10: Global: Intrauterine Devices (Hormonal) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Intrauterine Devices (Hormonal) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Intrauterine Devices (Copper) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Intrauterine Devices (Copper) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Intrauterine Devices (End-Use in Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Intrauterine Devices (End-Use in Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Intrauterine Devices (End-Use in Community Healthcare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Intrauterine Devices (End-Use in Community Healthcare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Intrauterine Devices (Other End-Uses) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Intrauterine Devices (Other End-Uses) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Europe: Intrauterine Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Europe: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: Intrauterine Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Asia Pacific: Intrauterine Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Asia Pacific: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Middle East and Africa: Intrauterine Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Middle East and Africa: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Latin America: Intrauterine Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Latin America: Intrauterine Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Intrauterine Devices Manufacturing: Detailed Process Flow
List of Tables
Table 1: Global: Intrauterine Devices Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Intrauterine Devices Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Intrauterine Devices Market Forecast: Breakup by End-Use (in Million US$), 2022-2027
Table 4: Global: Intrauterine Devices Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Intrauterine Devices Manufacturing: Raw Material Requirements
Table 6: Global: Intrauterine Devices Market: Competitive Structure
Table 7: Global: Intrauterine Devices Market: Key Players